1. Adami G, Saag KG. Glucocorticoid-induced osteoporosis update. Curr Opin Rheumatol. 2019;31(4):388-393. https://doi.org/10.1097/BOR.0000000000000608
2. Chiodini I, Merlotti D, Falchetti A, Gennari L. Treatment options for glucocorticoid-induced osteoporosis. Expert opinion on pharmacotherapy. 2020;21(6):721-732. https://doi.org/10.1080/14656566.2020.1721467
3. Masaki H, Miki T. [Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)]. Clinical calcium. 2006;16(11):1823-1832.
4. Komori T. Glucocorticoid Signaling and Bone Biology. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2016;48(11):755-763.
5. Han L, Wang B, Wang R, Gong S, Chen G, Xu W. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor. Stem cell research & therapy. 2019;10(1):377. https://doi.org/10.1186/s13287-019-1498-0
6. Alagiakrishnan K, Mereu LE, Tsuyuki RT, Kalisiak M, Sclater A, Hervas-Malo M. Cholesterol and osteoporosis in postmenopausal women: a pilot study. Journal of the American Geriatrics Society. 2003;51(10):1510-1511.
7. Leutner M, Matzhold C, Bellach L, et al. Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Annals of the rheumatic diseases. 2019;78(12):1706-1711. https://doi.org/10.1136/annrheumdis-2019-215714
8. Reed RM, Wise RA, Dobs AS, Lechtzin N, Girgis RE. Elevated HDL cholesterol levels are associated with osteoporosis in lung transplant candidates with chronic obstructive pulmonary disease. Respiratory medicine. 2010;104(12):1943-1950. https://doi.org/10.1016/j.rmed.2010.08.004
9. Sun S, Adyshev D, Dudek S, Paul A, McColloch A, Cho M. Cholesterol-dependent Modulation of Stem Cell Biomechanics: Application to Adipogenesis. Journal of biomechanical engineering. 2019;https://doi.org/10.1115/1.4043253
10. Viccica G, Vignali E, Marcocci C. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation. Journal of endocrinological investigation. 2007;30(6 Suppl)
11. Mandal CC. High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms. Frontiers in endocrinology. 2015;6:165. https://doi.org/10.3389/fendo.2015.00165
12. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA. 2000;283(24):3205-3210.
13. Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet (London, England). 2000;355(9222):2218-2219.
14. Ghosh-Choudhury N, Mandal CC, Choudhury GG. Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. The Journal of biological chemistry. 2007;282(7):4983-4993.
15. Huang P, Nedelcu D, Watanabe M, et al. Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling. Cell. 2016;166(5)https://doi.org/10.1016/j.cell.2016.08.003
16. Luchetti G, Sircar R, Kong JH, et al. Cholesterol activates the G-protein coupled receptor Smoothened to promote Hedgehog signaling. eLife. 2016;5https://doi.org/10.7554/eLife.20304
17. Almon RR, Dubois DC, Jin JY, Jusko WJ. Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle. J Endocrinol. 2005;184(1):219-232.
18. Noebauer B, Jais A, Todoric J, Gossens K, Sutterlüty-Fall H, Einwallner E. Hepatic Cholesterol-25-Hydroxylase Overexpression Improves Systemic Insulin Sensitivity in Mice. J Diabetes Res. 2017;2017:4108768. https://doi.org/10.1155/2017/4108768
19. Raselli T, Wyss A, Gonzalez Alvarado MN, et al. The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis. J Crohns Colitis. 2019;13(9):1186-1200. https://doi.org/10.1093/ecco-jcc/jjz039
20. Bardai G, Lemyre E, Moffatt P, et al. Osteogenesis Imperfecta Type I Caused by COL1A1 Deletions. Calcif Tissue Int. 2016;98(1):76-84.
21. Besio R, Maruelli S, Battaglia S, et al. Early Fracture Healing is Delayed in the Col1a2 Osteogenesis Imperfecta Murine Model. Calcif Tissue Int. 2018;103(6):653-662. https://doi.org/10.1007/s00223-018-0461-x
22. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274-293. https://doi.org/10.1016/j.cell.2012.03.017
23. Chen C, Akiyama K, Wang D, et al. mTOR inhibition rescues osteopenia in mice with systemic sclerosis. J Exp Med. 2015;212(1):73-91. https://doi.org/10.1084/jem.20140643
24. Hadji P, Coleman R, Gnant M. Bone effects of mammalian target of rapamycin (mTOR) inhibition with everolimus. Crit Rev Oncol Hematol. 2013;87(2):101-111. https://doi.org/10.1016/j.critrevonc.2013.05.015
25. Lynch CJ, Patson BJ, Anthony J, Vaval A, Jefferson LS, Vary TC. Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue. American journal of physiology Endocrinology and metabolism. 2002;283(3):E503-E513.
26. Fox HL, Kimball SR, Jefferson LS, Lynch CJ. Amino acids stimulate phosphorylation of p70S6k and organization of rat adipocytes into multicellular clusters. The American journal of physiology. 1998;274(1):C206-C213. https://doi.org/10.1152/ajpcell.1998.274.1.C206
27. Roh C, Han J, Tzatsos A, Kandror KV. Nutrient-sensing mTOR-mediated pathway regulates leptin production in isolated rat adipocytes. American journal of physiology Endocrinology and metabolism. 2003;284(2):E322-E330.
28. Kim JE, Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes. 2004;53(11):2748-2756.
29. Liu Y, Kou X, Chen C, et al. Chronic High Dose Alcohol Induces Osteopenia via Activation of mTOR Signaling in Bone Marrow Mesenchymal Stem Cells. Stem Cells. 2016;34(8):2157-2168. https://doi.org/10.1002/stem.2392
30. Sun S, Zhou L, Yu Y, Zhang T, Wang M. Knocking down clock control gene CRY1 decreases adipogenesis via canonical Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 2018;506(3):746-753. https://doi.org/10.1016/j.bbrc.2018.10.134
31. Zhou L, Sun S, Xu L, Yu Y, Zhang T, Wang M. DExH-Box helicase 58 enhances osteoblast differentiation of osteoblastic cells via Wnt/β-Catenin signaling. Biochem Biophys Res Commun. 2019;511(2):307-311. https://doi.org/10.1016/j.bbrc.2019.02.039
32. Xiang X, Zhao J, Xu G, Li Y, Zhang W. mTOR and the differentiation of mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai). 2011;43(7):501-510. https://doi.org/10.1093/abbs/gmr041
33. Adami G, Saag KG. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int. 2019;30(6):1145-1156. https://doi.org/10.1007/s00198-019-04906-x
34. Li G-W, Xu Z, Chen Q-W, Chang S-X, Tian Y-N, Fan J-Z. The temporal characterization of marrow lipids and adipocytes in a rabbit model of glucocorticoid-induced osteoporosis. Skeletal Radiol. 2013;42(9):1235-1244. https://doi.org/10.1007/s00256-013-1659-7
35. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci. 1992;102 ( Pt 2):341-351.
36. Gimble JM, Robinson CE, Wu X, Kelly KA. The function of adipocytes in the bone marrow stroma: an update. Bone. 1996;19(5):421-428.
37. Yu W, Chen Z, Zhang J, et al. Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Mol Cell Biochem. 2008;310(1-2):11-18.
38. Martin SK, Fitter S, Dutta AK, et al. Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells. 2015;33(4):1359-1365. https://doi.org/10.1002/stem.1931
39. Zhang HH, Huang J, Düvel K, et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One. 2009;4(7):e6189. https://doi.org/10.1371/journal.pone.0006189
40. Yeh WC, Bierer BE, McKnight SL. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A. 1995;92(24):11086-11090.
41. Walther TC, Farese RV. Lipid droplets and cellular lipid metabolism. Annual review of biochemistry. 2012;81:687-714. https://doi.org/10.1146/annurev-biochem-061009-102430
42. Brown MS, Dana SE, Goldstein JL. Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols. The Journal of biological chemistry. 1975;250(10):4025-4027.
43. Lehmann JM, Kliewer SA, Moore LB, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. The Journal of biological chemistry. 1997;272(6):3137-3140.
44. Ouyang W, Zhou H, Liu C, et al. 25-Hydroxycholesterol protects against acute lung injury via targeting MD-2. Journal of cellular and molecular medicine. 2018;22(11):5494-5503. https://doi.org/10.1111/jcmm.13820
45. Park K, Scott AL. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. Journal of leukocyte biology. 2010;88(6):1081-1087. https://doi.org/10.1189/jlb.0610318
46. Hashimoto Y, Matsuzaki E, Higashi K, et al. Sphingosine-1-phosphate inhibits differentiation of C3H10T1/2 cells into adipocyte. Mol Cell Biochem. 2015;401(1-2):39-47. https://doi.org/10.1007/s11010-014-2290-1
47. Chen S-Z, Xu X, Ning L-F, et al. miR-27 impairs the adipogenic lineage commitment via targeting lysyl oxidase. Obesity (Silver Spring). 2015;23(12):2445-2453. https://doi.org/10.1002/oby.21319
48. Guan X, Gao Y, Zhou J, et al. miR-223 Regulates Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells Through a C/EBPs/miR-223/FGFR2 Regulatory Feedback Loop. Stem Cells. 2015;33(5):1589-1600. https://doi.org/10.1002/stem.1947
49. Tang Z, Xu T, Li Y, Fei W, Yang G, Hong Y. Inhibition of CRY2 by STAT3/miRNA-7-5p Promotes Osteoblast Differentiation through Upregulation of CLOCK/BMAL1/P300 Expression. Molecular therapy Nucleic acids. 2020;19:865-876. https://doi.org/10.1016/j.omtn.2019.12.020